The mechanisms underlying functional mitral regurgitation (MR) and the relation between mechanism and severity of MR have not been evaluated in a large, multicenter, randomized controlled trial. Transesophageal echocardiography (TEE) was performed in 215 patients at 17 centers in the Surgical Treatment for Ischemic Heart Failure (STICH) trial. Both 2-dimensional (n [ 215) and 3-dimensional (n [ 81) TEEs were used to assess multiple quantitative measurements of the mechanism and severity of MR. By 2-dimensional TEE, leaflet tenting area, anterior and posterior leaflet angles, mitral annulus diameter, left ventricular (LV) end-systolic volume index, LV ejection fraction (LVEF), and sphericity index (p <0.05 for all) were significantly different across MR grades. By 3-dimensional TEE, mitral annulus area, leaflet tenting area, LV end-systolic volume index, LVEF, and sphericity index (p <0.05 for all) were significantly different across MR grades. A multivariate analysis showed a trend for annulus area (p [ 0.069) and LV end-systolic volume index (p [ 0.071) to predict effective regurgitant orifice area and for annulus area (p [ 0.018) and LV end-systolic volume index (p [ 0.073) to predict vena contracta area. In the STICH trial, multiple quantitative parameters of the mechanism of functional MR are related to MR severity. The mechanism of functional MR in ischemic cardiomyopathy is heterogenous, but no single variable stands out as a strong predictor of quantitative severity of MR. Ó 2013 Elsevier Inc. All rights reserved. (Am J Cardiol 2013;112:1812e1818) Functional mitral regurgitation (MR) is a common complication of ischemic heart disease, which is associated with increased mortality. 1e5 Early studies of the mechanism of functional MR focused on mitral annular dilation and loss of systolic annular contraction due to left ventricular (LV) dilation, 6 diminished mitral leaflet closing force, 7 and abnormal LV shape. 8 More recently, it has been shown that functional MR is caused by leaflet tethering as the papillary muscles are displaced apically and laterally by LV dilation. 9e13 Papillary muscle displacement may be due to global or regional wall motion abnormalities and may be symmetric or asymmetric. 14 Understanding the mechanisms of functional MR in any given patient has important implications regarding the correct approach to repair it. To date, neither large prospective studies have examined the mechanism(s) underlying functional MR in ischemic cardiomyopathy nor has the relation between mechanism and severity of functional MR been determined. This is a report of a prospectively defined ancillary study to the Surgical Treatment for Ischemic Heart Failure (STICH) trial, in which 2-dimensional (2D) and 3-dimensional (3D) transesophageal echocardiographies (TEE) were used to define the mechanism(s) of functional MR in a large clinical trial of patients with ischemic cardiomyopathy randomized to medical therapy, coronary bypass grafting, or coronary bypass grafting plus surgical ventricular restoration. 15, 16 Methods All participating STICH study sites were invited to participate in the STICH MR TEE substudy; 17 accepted.
The mechanisms underlying functional mitral regurgitation (MR) and the relation between mechanism and severity of MR have not been evaluated in a large, multicenter, randomized controlled trial. Transesophageal echocardiography (TEE) was performed in 215 patients at 17 centers in the Surgical Treatment for Ischemic Heart Failure (STICH) trial. Both 2-dimensional (n [ 215) and 3-dimensional (n [ 81) TEEs were used to assess multiple quantitative measurements of the mechanism and severity of MR. By 2-dimensional TEE, leaflet tenting area, anterior and posterior leaflet angles, mitral annulus diameter, left ventricular (LV) end-systolic volume index, LV ejection fraction (LVEF), and sphericity index (p <0.05 for all) were significantly different across MR grades. By 3-dimensional TEE, mitral annulus area, leaflet tenting area, LV end-systolic volume index, LVEF, and sphericity index (p <0.05 for all) were significantly different across MR grades. A multivariate analysis showed a trend for annulus area (p [ 0.069) and LV end-systolic volume index (p [ 0.071) to predict effective regurgitant orifice area and for annulus area (p [ 0.018) and LV end-systolic volume index (p [ 0.073) to predict vena contracta area. In the STICH trial, multiple quantitative parameters of the mechanism of functional MR are related to MR severity. The mechanism of functional MR in ischemic cardiomyopathy is heterogenous, but no single variable stands out as a strong predictor of quantitative severity of MR. Ó 2013 Elsevier Inc. All rights reserved. (Am J Cardiol 2013;112:1812e1818) Functional mitral regurgitation (MR) is a common complication of ischemic heart disease, which is associated with increased mortality. 1e5 Early studies of the mechanism of functional MR focused on mitral annular dilation and loss of systolic annular contraction due to left ventricular (LV) dilation, 6 diminished mitral leaflet closing force, 7 and abnormal LV shape. 8 More recently, it has been shown that functional MR is caused by leaflet tethering as the papillary muscles are displaced apically and laterally by LV dilation. 9e13 Papillary muscle displacement may be due to global or regional wall motion abnormalities and may be symmetric or asymmetric. 14 Understanding the mechanisms of functional MR in any given patient has important implications regarding the correct approach to repair it. To date, neither large prospective studies have examined the mechanism(s) underlying functional MR in ischemic cardiomyopathy nor has the relation between mechanism and severity of functional MR been determined. This is a report of a prospectively defined ancillary study to the Surgical Treatment for Ischemic Heart Failure (STICH) trial, in which 2-dimensional (2D) and 3-dimensional (3D) transesophageal echocardiographies (TEE) were used to define the mechanism(s) of functional MR in a large clinical trial of patients with ischemic cardiomyopathy randomized to medical therapy, coronary bypass grafting, or coronary bypass grafting plus surgical ventricular restoration. 15, 16 Methods All participating STICH study sites were invited to participate in the STICH MR TEE substudy; 17 accepted. All 17 sites were provided with a detailed study protocol for obtaining TEE images to define the mechanism and severity of functional MR. 17e19 An Institutional Review Board approval was obtained from each site, and written informed consent was obtained from all patients. At the time the STICH trial was initiated, real-time 3D imaging was not available. Sites equipped with a Philips ultrasound machine (Philips Ultrasound, Andover, Massachusetts) were capable of 3D TEE acquisitions using a rotational reconstruction algorithm. 20 Philips graciously provided the 3D software to those sites. For patients in STICH trial randomized to medical therapy, TEE was done within 1 week of randomization. For patients randomized to surgery, a baseline preoperative TEE was done within 1 week before surgery. Intraoperative TEE was excluded by the study protocol because general anesthesia dramatically reduces the severity of MR by TEE. 21 TEE was performed during intravenous conscious sedation and local oropharyngeal anesthesia. Heart rate, blood pressure, oxygen saturation, and electrocardiogram were monitored throughout the procedure. Transgastric short-axis views of the LV were obtained at the midpapillary muscle and mitral leaflet levels. A transgastric long-axis view was also oriented to show both papillary muscles with their chordal attachments to the mitral leaflets. From the midesophagus, the probe was retroflexed to obtain a 4-chamber view with care to maximize LV cavity length and width while keeping the LV long axis in the center of the imaging sector. From this position, the imaging plane was manually rotated to obtain a commissural view, a 2-chamber view, and a long-axis view. For sites with 3D capability, at least two 3D rotational scans were obtained in each patient. Translational artifacts secondary to patient respiration were minimized using a proprietary software to automatically capture images within a defined respiratory threshold. After obtaining a well-aligned 4-chamber view, the probe was rotated automatically in 6 increments by the 3D TEE software across a total of 180 . These images were downloaded onto a 5.25 00 magneto-optic disk and sent to the core laboratory, where analysis was performed in a blinded fashion using a custom software (Omni 4D; Massachusetts General Hospital, Boston, Massachusetts). This offered several advantages with regard to quality control. First, this software has been previously validated in vitro and in vivo. 10e13 Second, it allowed the different TEE operators at different STICH sites to get consistent high-quality data from a single midesophageal probe position during quiet respiration or breath hold. Third, it allowed more accurate measurements without confounding by foreshortened or offaxis views or flattening of 3D measurements onto a 2D display screen.
The mechanism(s) of functional MR was assessed by quantitative measurements including leaflet tethering distance, tethering angle, tenting area, papillary muscle displacement, and annulus area at end-diastole and endsystole. Three-dimensional TEE data sets were analyzed using the method by Otsuji et al. 11 Manual tracing was used to identify the hinge points of the mitral leaflet insertion to identify the mitral annulus in each rotational imaging plane. The aortic annulus was identified by the hinge points of aortic leaflet insertion, and the intersection of the aortic and mitral annuli allowed identification of the medial and lateral fibrous trigones. The tips of the papillary muscles were also identified. In cases with complex papillary muscle anatomy, the largest papillary muscle head, which was most centrally located, was selected. All these points were assigned different colors by the Omni 4D software so that they could be tracked in 3D (Figure 1 ). The computer allowed rotation of the images to facilitate analysis. The software then automatically calculated the mitral annulus areas at end-diastole and end-systole, the percent systolic contraction of the mitral annulus, the papillary muscle separation distance, the mitral tenting area and height, the papillary muscle separation angle (angle from the posteromedial papillary muscle to the medial trigone to the anterolateral papillary muscle), and the distances between the medial trigone and the posteromedial and anterolateral papillary muscles. 
Valvular Heart Disease/Mechanisms of Functional MR in STICH
In addition to the mechanistic variables measured from TEE images, core laboratory evaluations of LV end-diastolic volume index and end-systolic volume index, LV ejection fraction (LVEF), and sphericity index were available from the STICH trial database. In the main STICH trial, all patients underwent baseline echocardiography, whereas magnetic resonance imaging and radionuclide imaging were optional. Using methods described previously, optimal LV volumes and LVEF were determined using an approach that incorporated all methods with the best correlation to overall mortality. 22 Quantitative measurements of MR severity, effective regurgitant orifice area (EROA), and vena contracta width Quantitative measurements of annulus size and leaflet tethering were compared in 3 groups of patients-those without MR, with mild MR (EROA <0.2 cm 2 ), and with at least moderate MR (EROA !0.2 cm 2 ). Specific measurements of MR mechanism were compared across MR grades. Analysis of variance was used to compare continuous variables of MR mechanism among the 3 groups of MR severity. Multivariate regression analysis was performed to evaluate which measurements of the mechanism of MR are independent predictors of MR severity as defined by (1) EROA and (2) VCW. For purposes of the multivariate analysis, EROA and VCW were assigned a value of 0 if MR was graded as none or trace.
Results
TEE studies were obtained in 214 subjects; of whom, 81 had both 2D and 3D TEEs performed and 134 had only 2D TEE. Of these, 210 studies (97.7%) were of sufficient quality to assess MR severity. There were 57 patients with no MR, 120 with mild, 29 with moderate, and 4 with severe MR. Of the subset of patients with 3D TEE, 26 had no MR, 44 had mild MR, and 11 had moderate or severe MR. Given the small sample of severe MR and the fact that even moderate MR portends a poor prognosis in heart failure, the moderate and severe MR grades were combined for statistical analysis. Table 1 lists the demographic and clinical characteristics of the patients in the MR substudy compared with the STICH main trial population not included in the substudy. In general, patients in the MR substudy were similar to those in the parent trial, being predominantly white men with a median age of 60 years. There was a greater predominance of whites in the substudy compared with the main trial (91.1% vs 76.6%, p <0.0001), more patients without angina (37.4% vs 30.5%, p ¼ 0.006), and more patients with New York Heart Association class I heart failure symptoms (20.1% vs 9.1%, p <0.0001). Patients in the MR substudy tended to have higher diastolic blood pressure (median of 80 vs 75 mm Hg, p ¼ 0.016) and higher LV end-systolic volume index (median of 82.5 vs 77.9 ml/m 2 , p ¼ 0.018). MR severity (as graded by the sites) tended to be slightly worse in patients in the MR substudy (moderate or severe MR in 27.8% vs 16.9%, p <0.001). Finally, patients in the MR substudy had slightly greater usage of the following medications: b blockers, angiotensin-converting enzyme inhibitors, diuretics, aspirin, aspirin or warfarin, and statins (p <0.05 for all). Table 2 lists the MR mechanistic variables by MR severity grades in the patients with 2D TEE studies. Multiple measurements were statistically significantly different across MR severity grades, including leaflet angle, posterior leaflet angle, mitral annulus diameter in the longaxis view (anteroposterior diameter), LV end-systolic volume index, LVEF, and sphericity index (p <0.05 for all).
The most strongly predictive measurement of MR grade was LV end-systolic volume index (77 ml/m 2 for none or trace MR, 81 ml/m 2 for mild MR, and 99.9 ml/m 2 for moderate or severe MR, p <0.001). Table 3 lists the results of MR mechanistic variables for the different grades of MR severity by 3D TEE. As with 2D TEE, multiple measurements showed statistically significant differences among MR grades, including end-diastolic and end-systolic mitral annulus areas, leaflet tenting area, LV end-systolic volume index, LVEF, and sphericity index (p 0.05 for all). Leaflet tethering distance (lateral trigone to lateral papillary muscle) tended to be longer in moderate or severe MR but was not statistically significant (p ¼ 0.092). The strongest association was with leaflet tenting area (1.6 cm 2 for none or trace MR, 1.9 cm 2 for mild MR, and 2.4 cm 2 for moderate or severe MR, p <0.001). Table 4 lists the results of a univariate analysis of various MR mechanistic variables as predictors of quantitative MR severity by EROA and VCW, as prespecified in the statistical analysis plan of the MR substudy. Statistically significant correlations were present between EROA and end-diastolic and end-systolic mitral annulus area, leaflet tenting area, baseline LV end-systolic volume index, and sphericity index. Statistically significant correlations existed between VCW and end-diastolic and end-systolic mitral annulus area by 3D TEE, leaflet tenting area, tethering distance from lateral trigone to lateral papillary muscle, baseline LV end-systolic volume index, and sphericity index. Table 5 lists the results of multivariate analysis using the variables that were statistically significant by univariate analysis. A trend was found between EROA and end-diastolic mitral annulus area (p ¼ 0.069) and LV end-systolic volume index (p ¼ 0.071). However, R-square values were weak, indicating that none of these variables were strong predictors of EROA. For VCW, only end-systolic annulus area was statistically significant (p ¼ 0.018), with a trend for LV endsystolic volume index (p ¼ 0.073).
Discussion
It has been well accepted that in ischemic cardiomyopathy, functional MR is primarily caused by LV dilation and/ or dysfunction, such that coaptation of normal or nearly normal mitral leaflets is prevented by a combination of reduced systolic closing force, leaflet tethering, and mitral annular dilation. This ancillary study of the STICH trial offered the opportunity to systematically assess many of these variables using high-resolution measurements of the mitral leaflets and annulus by TEE. The results showed that Table 4 Univariate analysis of the correlation between mechanism and quantitative severity of MR Multiple mechanistic variables were associated with qualitative MR grade, including anterior and posterior leaflet angles, anteroposterior mitral annulus diameter, LV endsystolic volume index, LVEF, and sphericity index in the subset of patients who had 2D TEE studies. The strongest of these were leaflet tenting area and LV end-systolic volume index, the only 2 variables with p values 0.001. In a smaller subset of 81 patients with 3D TEE, end-diastolic and end-systolic mitral annulus areas, leaflet tenting area, LV end-systolic volume index, LVEF, and sphericity index were statistically significantly associated with MR grade. The strongest of these were end-systolic mitral annulus area and mitral leaflet tenting area, both with p values 0.001.
For patients in whom EROA could be assessed quantitatively, significant correlations were found for annulus area, leaflet tenting area, LV end-systolic volume index, and sphericity index on univariate analysis. However, on multivariate analysis, none of these variables were significantly related to EROA, although there was a trend for enddiastolic annulus area and LV end-systolic volume index. Similar findings were present for VCW, in which only endsystolic annulus area was statistically significant and there was a trend for LV end-systolic volume index. This is probably explained by a strong degree of correlation between the mechanistic variables, which is consistent with the prevailing hypothesis that functional MR is a consequence of LV dilation and dysfunction.
Most of our data come from 2D TEE because many participating sites did not have 3D capability. At the time of recruitment into the STICH trial, the 3D rotational imaging used in this study was state of the art. However, current 3D imaging techniques use real-time imaging, which is less prone to translational artifacts and is recommended for evaluation of mitral valve morphology 25 and quantitation of functional MR severity by planimetry of the vena contracta area. 26 The final analysis was conducted based on the data taken from 3 different sources: 2D TEE, 3D TEE, and assessment of LV size and by 2D transthoracic echocardiography, radionuclide angiography, and cine magnetic resonance. This may raise doubts about the homogeneity of data.
Finally, the STICH inclusion criteria stipulated enrolling patients with heart failure due to ischemic cardiomyopathy, LVEF 35%, and anterior akinesia. Patients with functional MR due to isolated inferior or posterolateral wall motion abnormalities are not represented. In such patients, leaflet tethering is likely to play a larger role in the mechanism of functional MR.
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